New Risk • Mar 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported April 2023 fiscal period end). High level of non-cash earnings (67% accrual ratio). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Market cap is less than US$10m (JP¥1.28b market cap, or US$8.04m). Minor Risk Share price has been volatile over the past 3 months (6.5% average weekly change). 공시 • Dec 27
Manabi-aid Co.,Ltd. to Report Q3, 2026 Results on Mar 17, 2026 Manabi-aid Co.,Ltd. announced that they will report Q3, 2026 results on Mar 17, 2026 New Risk • Dec 19
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: JP¥1.55b (US$9.86m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported April 2023 fiscal period end). High level of non-cash earnings (67% accrual ratio). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Market cap is less than US$10m (JP¥1.55b market cap, or US$9.86m). Minor Risk Share price has been volatile over the past 3 months (5.5% average weekly change). 공시 • Sep 27
Manabi-aid Co.,Ltd. to Report Q2, 2026 Results on Dec 15, 2025 Manabi-aid Co.,Ltd. announced that they will report Q2, 2026 results on Dec 15, 2025 공시 • Jul 29
Manabi-aid Co.,Ltd. to Report Q1, 2026 Results on Sep 16, 2025 Manabi-aid Co.,Ltd. announced that they will report Q1, 2026 results on Sep 16, 2025 New Risk • Jun 21
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 52% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported April 2023 fiscal period end). Share price has been highly volatile over the past 3 months (13% average weekly change). High level of non-cash earnings (67% accrual ratio). Shareholders have been substantially diluted in the past year (52% increase in shares outstanding). Minor Risk Market cap is less than US$100m (JP¥2.15b market cap, or US$14.7m). 공시 • Apr 01
Manabi-aid Co.,Ltd. to Report Fiscal Year 2025 Results on Jun 13, 2025 Manabi-aid Co.,Ltd. announced that they will report fiscal year 2025 results on Jun 13, 2025 공시 • Jan 28
Manabi-aid Co.,Ltd. to Report Q3, 2025 Results on Mar 17, 2025 Manabi-aid Co.,Ltd. announced that they will report Q3, 2025 results on Mar 17, 2025 New Risk • Oct 30
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (JP¥1.31b market cap, or US$8.54m). Valuation Update With 7 Day Price Move • Oct 10
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to JP¥790, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 16x in the Consumer Services industry in Japan. 공시 • Sep 28
Manabi-aid Co.,Ltd. to Report Q2, 2025 Results on Dec 13, 2024 Manabi-aid Co.,Ltd. announced that they will report Q2, 2025 results on Dec 13, 2024 New Risk • Aug 05
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: JP¥1.33b (US$9.36m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (67% accrual ratio). Market cap is less than US$10m (JP¥1.33b market cap, or US$9.36m). Minor Risk Revenue is less than US$5m (JP¥501m revenue, or US$3.5m). Valuation Update With 7 Day Price Move • Jul 24
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to JP¥839, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 17x in the Consumer Services industry in Japan. 공시 • Jul 06
Manabi-aid Co.,Ltd. to Report Q1, 2025 Results on Sep 13, 2024 Manabi-aid Co.,Ltd. announced that they will report Q1, 2025 results on Sep 13, 2024 Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to JP¥1,066, the stock trades at a trailing P/E ratio of 25.7x. Average trailing P/E is 16x in the Consumer Services industry in Japan. 공시 • May 30
Manabi-aid Co.,Ltd. has completed an IPO in the amount of ¥710.04 million. Manabi-aid Co.,Ltd. has completed an IPO in the amount of ¥710.04 million.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 180,000
Price\Range: ¥970
Discount Per Security: ¥77.6
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 552,000
Price\Range: ¥970
Discount Per Security: ¥77.6
Transaction Features: Sponsor Backed Offering Board Change • May 28
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. 1 experienced director. No highly experienced directors. No independent directors (3 non-independent directors). Auditor Kazuhisa Hayashida is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors.